BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July

Day

• 1
• 2
• 3
• 4
• 7
• 8
• 9
• 10
• 11
• 14
• 15
• 16
• 17
• 18

• Press Releases

  Uniphar Rebrands On Demand Business to Uniphar Global Sourcing, Strengthening Global Pharmaceutical Offering

  July 17, 2025

   · 

  1 min read
• Press Releases

  Maxwell Biosciences Announces AI Department & Hiring of Jon McClure

  New leadership to spearhead AI-driven breakthroughs in drug discovery and operational excellence

  July 17, 2025

   · 

  4 min read
• Press Releases

  NervGen Announces Leadership Transition to Support Strategic Growth and Expansion

  Chairman Dr. Adam Rogers Appointed Interim CEO Following Landmark Positive Chronic Spinal Cord Injury Trial Results

  July 17, 2025

   · 

  7 min read
• Press Releases

  Hairy Cell Leukemia Market to Surpass USD 223.3 Million in 2032, Driven by Rising Cases of Rare Hematologic Cancers | Coherent Market Insights

  July 17, 2025

   · 

  1 min read
• Press Releases

  Instem Announces Provantis® 12: A Powerful Step Forward in Preclinical Study Management

  July 17, 2025

   · 

  3 min read
• Press Releases

  Exactech Appoints New Chief Medical Officer

  July 17, 2025

   · 

  3 min read
• Press Releases

  Oncotelic Therapeutics Highlights Peer‑Reviewed Publication Linking TGFB2 to Survival in Younger Pancreatic Cancer Patients

  July 17, 2025

   · 

  6 min read
• Press Releases

  Feinstein Institutes Researchers Find COVID-19 Vaccine Boosters Offer Significant Protection for Cancer Patients

  July 17, 2025

   · 

  2 min read
• Press Releases

  PureTech Founded Entity Seaport Therapeutics Announces First Patient Dosed in Phase 2b BUOY-1 Study of GlyphAllo™ (SPT-300) in Major Depressive Disorder (MDD), With or Without Anxious Distress

  July 17, 2025

   · 

  10 min read
• Press Releases

  DiaMedica Therapeutics Reports Positive Interim Phase 2 Preeclampsia Results: Statistically Significant Reductions in Blood Pressure and No Placental Transfer

  July 17, 2025

   · 

  11 min read